HEADER TRANSFERASE 01-MAY-07 2UZT TITLE PKA STRUCTURES OF AKT, INDAZOLE-PYRIDINE INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 15-350; COMPND 5 SYNONYM: PKA C-ALPHA, PROTEIN KINASE A; COMPND 6 EC: 2.7.11.11; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES 5-24; COMPND 12 SYNONYM: PKI-ALPHA, INIBITORY PEPTIDE; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: BOVINE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 10 ORGANISM_TAXID: 9913 KEYWDS CAMP, KINASE, MYRISTATE, TRANSFERASE, LIPOPROTEIN, SERINE/THREONINE- KEYWDS 2 PROTEIN KINASE, PHOSPHORYLATION, PROTEIN KINASE A, NUCLEOTIDE- KEYWDS 3 BINDING, PROTEIN KINASE INHIBITOR, ATP- BINDING, AKT INHIBITORS, KEYWDS 4 NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.D.ZHU,V.B.GANDHI,J.GONG,S.THOMAS,K.W.WOODS,X.SONG,T.LI,R.B.DIEBOLD, AUTHOR 2 Y.LUO,X.LIU,R.GUAN,V.KLINGHOFER,E.F.JOHNSON,J.BOUSKA,A.OLSON, AUTHOR 3 K.C.MARSH,V.S.STOLL,M.MAMO,J.POLAKOWSKI,T.J.CAMPBELL,T.D.PENNING, AUTHOR 4 Q.LI,S.H.ROSENBERG,V.L.GIRANDA REVDAT 4 08-MAY-24 2UZT 1 REMARK REVDAT 3 24-FEB-09 2UZT 1 VERSN REVDAT 2 03-JUL-07 2UZT 1 JRNL REVDAT 1 05-JUN-07 2UZT 0 JRNL AUTH G.D.ZHU,V.B.GANDHI,J.GONG,S.THOMAS,K.W.WOODS,X.SONG,T.LI, JRNL AUTH 2 R.B.DIEBOLD,Y.LUO,X.LIU,R.GUAN,V.KLINGHOFER,E.F.JOHNSON, JRNL AUTH 3 J.BOUSKA,A.OLSON,K.C.MARSH,V.S.STOLL,M.MAMO,J.POLAKOWSKI, JRNL AUTH 4 T.J.CAMPBELL,R.L.MARTIN,G.A.GINTANT,T.D.PENNING,Q.LI, JRNL AUTH 5 S.H.ROSENBERG,V.L.GIRANDA JRNL TITL SYNTHESES OF POTENT, SELECTIVE, AND ORALLY BIOAVAILABLE JRNL TITL 2 INDAZOLE-PYRIDINE SERIES OF PROTEIN KINASE B/AKT INHIBITORS JRNL TITL 3 WITH REDUCED HYPOTENSION. JRNL REF J.MED.CHEM. V. 50 2990 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17523610 JRNL DOI 10.1021/JM0701019 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.2 REMARK 3 NUMBER OF REFLECTIONS : 24660 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.273 REMARK 3 FREE R VALUE : 0.313 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.700 REMARK 3 FREE R VALUE TEST SET COUNT : 2443 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3731 REMARK 3 BIN R VALUE (WORKING SET) : 0.2730 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 433 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2927 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.24900 REMARK 3 B22 (A**2) : 4.15500 REMARK 3 B33 (A**2) : 6.09400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.08 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 39.20 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : LIG.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : LIG.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2UZT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1290032444. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28058 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.82 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.58250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.42300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.13100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.42300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.58250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.13100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO A 124 CG CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 199 CB CYS A 199 SG -0.106 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 36 82.02 18.34 REMARK 500 ALA A 38 178.80 178.01 REMARK 500 LYS A 47 149.86 -170.22 REMARK 500 SER A 53 -98.33 -0.67 REMARK 500 ASP A 166 49.30 -149.67 REMARK 500 ASP A 184 90.19 69.44 REMARK 500 SER A 212 35.68 39.95 REMARK 500 LYS A 317 160.17 -46.31 REMARK 500 LYS A 342 -126.00 -90.32 REMARK 500 CYS A 343 57.63 -56.96 REMARK 500 HIS B 23 -67.74 -103.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SS3 A1351 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1KMU RELATED DB: PDB REMARK 900 MODEL STRUCTURE OF THE CATALYTIC SUBUNIT- REGULATORY SUBUNITDIMERIC REMARK 900 COMPLEX OF THE CAMP -DEPENDENT PROTEIN KINASE REMARK 900 RELATED ID: 1KMW RELATED DB: PDB REMARK 900 MODEL STRUCTURE OF THE CATALYTIC SUBUNIT- REGULATORY SUBUNITDIMERIC REMARK 900 COMPLEX OF THE C- AMP-DEPENDENT PROTEIN KINASE REMARK 900 RELATED ID: 1Q24 RELATED DB: PDB REMARK 900 PKA DOUBLE MUTANT MODEL OF PKB IN COMPLEX WITH MGATP REMARK 900 RELATED ID: 1Q61 RELATED DB: PDB REMARK 900 PKA TRIPLE MUTANT MODEL OF PKB REMARK 900 RELATED ID: 1Q62 RELATED DB: PDB REMARK 900 PKA DOUBLE MUTANT MODEL OF PKB REMARK 900 RELATED ID: 1Q8T RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE(PKA) IN REMARK 900 COMPLEX WITH RHO- KINASE INHIBITOR Y-27632 REMARK 900 RELATED ID: 1Q8U RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE INCOMPLEX REMARK 900 WITH RHO-KINASE INHIBITOR H-1152P REMARK 900 RELATED ID: 1Q8W RELATED DB: PDB REMARK 900 THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE INCOMPLEX REMARK 900 WITH RHO-KINASE INHIBITOR FASUDIL (HA-1077) REMARK 900 RELATED ID: 1SMH RELATED DB: PDB REMARK 900 PROTEIN KINASE A VARIANT COMPLEX WITH COMPLETELY ORDERED N-TERMINAL REMARK 900 HELIX REMARK 900 RELATED ID: 1STC RELATED DB: PDB REMARK 900 CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT INCOMPLEX REMARK 900 WITH STAUROSPORINE REMARK 900 RELATED ID: 1SVE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE REMARK 900 DERIVATIVE 1 REMARK 900 RELATED ID: 1SVG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE REMARK 900 DERIVATIVE 4 REMARK 900 RELATED ID: 1SVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE REMARK 900 DERIVATIVE 8 REMARK 900 RELATED ID: 1SZM RELATED DB: PDB REMARK 900 DUAL BINDING MODE OF BISINDOLYLMALEIMIDE 2 TO PROTEINKINASE A (PKA) REMARK 900 RELATED ID: 1VEB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PROTEIN KINASE A IN COMPLEX WITHAZEPANE REMARK 900 DERIVATIVE 5 REMARK 900 RELATED ID: 1XH4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XH9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1XHA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTEIN KINASE B SELECTIVE INHIBITORSIN REMARK 900 COMPLEX WITH PROTEIN KINASE A AND MUTANTS REMARK 900 RELATED ID: 1YDR RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTICSUBUNIT REMARK 900 IN COMPLEX WITH H7 PROTEIN KINASE INHIBITOR1-(5- REMARK 900 ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE REMARK 900 RELATED ID: 1YDS RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTICSUBUNIT REMARK 900 IN COMPLEX WITH H8 PROTEIN KINASE INHIBITOR[N-(2-METHYLAMINO) ETHYL] REMARK 900 -5-ISOQUINOLINESULFONAMIDE REMARK 900 RELATED ID: 1YDT RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTICSUBUNIT REMARK 900 IN COMPLEX WITH H89 PROTEIN KINASE INHIBITORN-[2-(4- REMARK 900 BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE REMARK 900 RELATED ID: 2C1A RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH REMARK 900 ISOQUINOLINE-5-SULFONIC ACID ( 2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO) REMARK 900 ETHYL) AMIDE REMARK 900 RELATED ID: 2C1B RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH (4R,2S)-5' REMARK 900 -(4-(4- CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL) ISOQUINOLINE REMARK 900 RELATED ID: 2F7E RELATED DB: PDB REMARK 900 PKA COMPLEXED WITH (S)-2-(1H-INDOL-3-YL )-1-(5-ISOQUINOLIN-6-YL- REMARK 900 PYRIDIN-3- YLOXYMETHYL-ETYLAMINE REMARK 900 RELATED ID: 2GFC RELATED DB: PDB REMARK 900 CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITHPKI-5-24 REMARK 900 RELATED ID: 2GNF RELATED DB: PDB REMARK 900 PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632 REMARK 900 RELATED ID: 2GNG RELATED DB: PDB REMARK 900 PROTEIN KINASE A FIVEFOLD MUTANT MODEL OF RHO-KINASE REMARK 900 RELATED ID: 2GNH RELATED DB: PDB REMARK 900 PKA FIVE FOLD MUTANT MODEL OF RHO-KINASE WITH H1152P REMARK 900 RELATED ID: 2GNI RELATED DB: PDB REMARK 900 PKA FIVEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITORFASUDIL REMARK 900 (HA1077) REMARK 900 RELATED ID: 2GNJ RELATED DB: PDB REMARK 900 PKA THREE FOLD MUTANT MODEL OF RHO-KINASE WITH Y-27632 REMARK 900 RELATED ID: 2GNL RELATED DB: PDB REMARK 900 PKA THREEFOLD MUTANT MODEL OF RHO-KINASE WITH INHIBITOR H-1152P REMARK 900 RELATED ID: 2JDS RELATED DB: PDB REMARK 900 STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A-443654 REMARK 900 RELATED ID: 2JDT RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH ISOQUINOLINE-5-SULFONIC REMARK 900 ACID (2-(2-(4- CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE REMARK 900 RELATED ID: 2JDV RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH A-443654 REMARK 900 RELATED ID: 2UVX RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 7-AZAINDOLE REMARK 900 RELATED ID: 2UVY RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH METHYL-(4-(9H-PURIN-6- REMARK 900 YL)-BENZYL)-AMINE REMARK 900 RELATED ID: 2UVZ RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH C-PHENYL-C-(4-(9H-PURIN- REMARK 900 6-YL)-PHENYL )-METHYLAMINE REMARK 900 RELATED ID: 2UW0 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 6-(4-(4-(4-CHLORO- REMARK 900 PHENYL)-PIPERIDIN-4- YL)-PHENYL)-9H-PURINE REMARK 900 RELATED ID: 2UW3 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 5-METHYL-4-PHENYL-1H- REMARK 900 PYRAZOLE REMARK 900 RELATED ID: 2UW4 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-(5-METHYL-1H- REMARK 900 PYRAZOL-4-YL)-PHENYL )-ETHYLAMINE REMARK 900 RELATED ID: 2UW5 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (R)-2-(4-CHLORO-PHENYL)- REMARK 900 2-(4-1H- PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE REMARK 900 RELATED ID: 2UW6 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (S)-2-(4-CHLORO-PHENYL)- REMARK 900 2-(4-1H- PYRAZOL-4-YL)-PHENYL)-ETHYLAMINE REMARK 900 RELATED ID: 2UW7 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 4-(4-CHLORO-PHENYL)-4- REMARK 900 (4-(1H-PYRAZOL-4 -YL)-PHENYL)-PIPERIDINE REMARK 900 RELATED ID: 2UW8 RELATED DB: PDB REMARK 900 STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH 2-(4-CHLORO-PHENYL)-2- REMARK 900 PHENYL-ETHYLAMINE REMARK 900 RELATED ID: 2UZU RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS REMARK 900 RELATED ID: 2UZW RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS REMARK 900 RELATED ID: 2UZV RELATED DB: PDB REMARK 900 PKA STRUCTURES OF INDAZOLE-PYRIDINE SERIES OF AKT INHIBITORS DBREF 2UZT A 15 350 UNP P00517 KAPCA_BOVIN 15 350 DBREF 2UZT B 5 24 UNP Q3SX13 IPKA_BOVIN 5 24 SEQADV 2UZT ASP A 286 UNP P00517 ASN 286 CONFLICT SEQRES 1 A 336 VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE LEU SEQRES 2 A 336 LYS LYS TRP GLU ASN PRO ALA GLN ASN THR ALA HIS LEU SEQRES 3 A 336 ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR GLY SER SEQRES 4 A 336 PHE GLY ARG VAL MET LEU VAL LYS HIS MET GLU THR GLY SEQRES 5 A 336 ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS VAL SEQRES 6 A 336 VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN GLU LYS SEQRES 7 A 336 ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL LYS SEQRES 8 A 336 LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR MET SEQRES 9 A 336 VAL MET GLU TYR VAL PRO GLY GLY GLU MET PHE SER HIS SEQRES 10 A 336 LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS ALA ARG SEQRES 11 A 336 PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR LEU SEQRES 12 A 336 HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO GLU SEQRES 13 A 336 ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN VAL THR SEQRES 14 A 336 ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG THR TRP SEQRES 15 A 336 THR LEU CYS GLY THR PRO GLU TYR LEU ALA PRO GLU ILE SEQRES 16 A 336 ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP TRP SEQRES 17 A 336 ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY TYR SEQRES 18 A 336 PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR GLU SEQRES 19 A 336 LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS PHE SEQRES 20 A 336 SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU GLN SEQRES 21 A 336 VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASP GLY SEQRES 22 A 336 VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR THR SEQRES 23 A 336 ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA PRO SEQRES 24 A 336 PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER ASN SEQRES 25 A 336 PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SER ILE SEQRES 26 A 336 ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 B 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 B 20 ARG ARG ASN ALA ILE HIS ASP HET SS3 A1351 27 HETNAM SS3 (2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}- HETNAM 2 SS3 3-PHENYLPROPAN-2-AMINE FORMUL 3 SS3 C22 H22 N4 O HELIX 1 1 VAL A 15 ASN A 32 1 18 HELIX 2 2 HIS A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLN A 84 GLN A 96 1 13 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 SER A 139 LEU A 160 1 22 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 THR A 201 LEU A 205 5 5 HELIX 9 9 ALA A 206 LEU A 211 1 6 HELIX 10 10 LYS A 217 GLY A 234 1 18 HELIX 11 11 GLN A 242 SER A 252 1 11 HELIX 12 12 SER A 262 LEU A 273 1 12 HELIX 13 13 VAL A 288 ASN A 293 1 6 HELIX 14 14 HIS A 294 ALA A 298 5 5 HELIX 15 15 ASP A 301 GLN A 307 1 7 HELIX 16 16 THR B 5 ALA B 12 1 8 SHEET 1 AA 5 PHE A 43 GLY A 52 0 SHEET 2 AA 5 GLY A 55 HIS A 62 -1 O GLY A 55 N GLY A 52 SHEET 3 AA 5 HIS A 68 ASP A 75 -1 O TYR A 69 N VAL A 60 SHEET 4 AA 5 ASN A 115 GLU A 121 -1 O LEU A 116 N LEU A 74 SHEET 5 AA 5 LEU A 106 LYS A 111 -1 N GLU A 107 O VAL A 119 SHEET 1 AB 2 LEU A 162 ILE A 163 0 SHEET 2 AB 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AC 2 LEU A 172 ILE A 174 0 SHEET 2 AC 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 SITE 1 AC1 15 LEU A 49 THR A 51 ALA A 70 LYS A 72 SITE 2 AC1 15 MET A 120 GLU A 121 TYR A 122 VAL A 123 SITE 3 AC1 15 GLU A 127 GLU A 170 ASN A 171 LEU A 173 SITE 4 AC1 15 THR A 183 ASP A 184 PHE A 327 CRYST1 59.165 78.262 100.846 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016902 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012778 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009916 0.00000